DOMAIN PARTERS VII L P
Insider CIK 1374150 · AKAO 10% owner · TBRA 10% owner · CADX 10% owner · EVOK 10% owner · OBLN 10% owner · ESPR 10% owner · TNDM 10% owner · CLVS 10% owner · NEOT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OBLN OBALON THERAPEUTICS INC | P Buy deriv | 2019-08-06 | 2019-08-08 | 187,500 | $4.00 | $750.0K | 187,500 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2019-08-06 | 2019-08-08 | 250,000 | $4.00 | $1.00M | 813,433 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | P Buy | 2018-08-23 | 2018-08-27 | 1,648,359 | $1.82 | $3.00M | 5,634,329 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 3,553,322 | $28.35 | $100.74M | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 597,207 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 1,206,836 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 482,326 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 649,835 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion deriv | 2016-10-12 | 2016-10-14 | 836,722 | — | $0 | 0 | SEC↗ |
| OBLN OBALON THERAPEUTICS INC | C Conversion | 2016-10-12 | 2016-10-14 | 3,985,970 | — | $0 | 3,985,970 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-05-26 | 2016-05-27 | 344,120 | $4.70 | $1.62M | 606,283 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-27 | 2016-04-27 | 3,603 | $5.02 | $18.1K | 950,403 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-25 | 2016-04-27 | 1,492 | $5.20 | $7.8K | 954,006 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-20 | 2016-04-21 | 4,424 | $5.29 | $23.4K | 955,498 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-19 | 2016-04-21 | 37,054 | $5.36 | $198.6K | 959,922 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-11 | 2016-04-13 | 4,348 | $5.22 | $22.7K | 996,976 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-08 | 2016-04-08 | 14,554 | $5.35 | $77.9K | 1,001,324 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-07 | 2016-04-08 | 27,781 | $5.26 | $146.1K | 1,015,878 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2016-04-06 | 2016-04-08 | 8,669 | $5.22 | $45.3K | 1,043,659 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-08-18 | 2015-08-20 | 11,836 | $7.02 | $83.1K | 1,052,328 | SEC↗ |
| TBRA Regado Biosciences Inc | P Buy | 2015-05-04 | 2015-05-06 | 277,777 | $10.62 | $2.95M | 3,553,322 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-16 | 2015-04-16 | 32,411 | $7.07 | $229.1K | 1,064,164 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-15 | 2015-04-16 | 7,920 | $7.58 | $60.0K | 1,096,575 | SEC↗ |
| EVOK Evoke Pharma Inc | S Sale | 2015-04-14 | 2015-04-16 | 9,832 | $7.78 | $76.5K | 1,104,495 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other | 2015-03-20 | 2015-03-24 | 350,000 | — | $0 | 2,216,935 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 2,164,305 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 6,111,968 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 737,422 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-26 | 7,252,144 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 92,105 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-11-26 | 165,790 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 7,252,144 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 2,164,305 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 6,111,968 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-12-10 | 737,422 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 165,790 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise deriv | 2014-11-25 | 2014-12-10 | 92,105 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 165,790 | $8.54 | $1.42M | 3,122,774 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-26 | 2,921,064 | — | $0 | 2,921,064 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-11-26 | 92,105 | $8.54 | $786.6K | 3,013,169 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-11-26 | 70,000 | $14.00 | $980.0K | 3,091,642 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 101,132 | $14.00 | $1.42M | 3,021,642 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-11-26 | 56,185 | $14.00 | $786.6K | 2,956,984 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 56,185 | $14.00 | $786.6K | 2,956,985 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 165,790 | $8.54 | $1.42M | 3,122,775 | SEC↗ |
| NEOT Neothetics, Inc. | F Tax w/h | 2014-11-25 | 2014-12-10 | 101,132 | $14.00 | $1.42M | 3,021,643 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-12-10 | 70,000 | $14.00 | $980.0K | 3,091,643 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-12-10 | 2,921,065 | — | $0 | 2,921,065 | SEC↗ |
| NEOT Neothetics, Inc. | M Exercise | 2014-11-25 | 2014-12-10 | 92,105 | $8.54 | $786.6K | 3,013,170 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 500,000 | $20.00 | $10.00M | 2,566,935 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 2,972,678 | $14.00 | $41.62M | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 435,663 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 625,065 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion deriv | 2014-03-17 | 2014-03-17 | 926,321 | — | $0 | 0 | SEC↗ |
| AKAO Achaogen Inc | C Conversion | 2014-03-17 | 2014-03-17 | 1,987,049 | — | $0 | 1,987,049 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,367,020 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | F Tax w/h | 2014-02-12 | 2014-02-14 | 765,532 | $14.00 | $10.72M | 2,972,678 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2014-02-12 | 2014-02-14 | 1,367,020 | $7.84 | $10.72M | 3,738,210 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 2,283,114 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 549,833 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 352,351 | — | $0 | 352,351 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | J Other deriv | 2013-11-19 | 2013-11-19 | 590,403 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion deriv | 2013-11-19 | 2013-11-19 | 356,111 | — | $0 | 0 | SEC↗ |
| TNDM TANDEM DIABETES CARE INC | C Conversion | 2013-11-19 | 2013-11-19 | 3,189,058 | — | $0 | 3,189,058 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion deriv | 2013-09-30 | 2013-09-30 | 1,114,327 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | C Conversion | 2013-09-30 | 2013-09-30 | 1,114,327 | — | $0 | 1,114,327 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 489,320 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-02 | 1,786,012 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-02 | 70,042 | — | $0 | 70,042 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-02 | 280,923 | $14.00 | $3.93M | 2,066,935 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-02 | 1,786,012 | — | $0 | 1,786,012 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-04 | 2013-06-05 | 159,192 | $64.58 | $10.28M | 2,581,745 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-15 | 2013-04-17 | 23,210 | $6.62 | $153.7K | 2,371,190 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-10 | 2013-04-10 | 1,567 | $6.72 | $10.5K | 2,394,400 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-09 | 2013-04-10 | 11,386 | $6.71 | $76.4K | 2,395,967 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-08 | 2013-04-10 | 12,217 | $6.52 | $79.7K | 2,407,353 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 4,374 | $5.35 | $23.4K | 2,419,570 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 5,510 | $5.22 | $28.8K | 2,423,944 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 7,925 | $5.19 | $41.1K | 2,429,454 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 8,020 | $5.16 | $41.4K | 2,437,379 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 9,636 | $5.28 | $50.9K | 2,445,399 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 5,020 | $5.36 | $26.9K | 2,455,035 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 7,733 | $5.40 | $41.8K | 2,460,055 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 6,346 | $5.38 | $34.1K | 2,467,788 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 4,118 | $5.34 | $22.0K | 2,474,134 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 5,154 | $5.32 | $27.4K | 2,478,252 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 12,701 | $5.22 | $66.3K | 2,483,406 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-06 | 2013-03-06 | 98,349 | $24.51 | $2.41M | 2,740,937 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 3,839 | $5.06 | $19.4K | 2,496,107 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-05 | 2013-03-06 | 126,868 | $24.69 | $3.13M | 2,839,286 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-05 | 2013-03-07 | 4,039 | $5.01 | $20.2K | 2,499,946 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-04 | 2013-03-05 | 5,145 | $5.01 | $25.8K | 2,503,985 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-03-04 | 2013-03-06 | 24,783 | $24.44 | $605.7K | 2,966,154 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-01 | 2013-03-05 | 7,635 | $5.01 | $38.3K | 2,509,130 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-20 | 2013-02-22 | 1,998 | $5.01 | $10.0K | 2,516,765 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-19 | 2013-02-20 | 10,076 | $5.02 | $50.6K | 2,518,763 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-15 | 2013-02-20 | 2,967 | $5.00 | $14.8K | 2,528,839 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-14 | 2013-02-15 | 2,951 | $5.01 | $14.8K | 2,531,806 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-13 | 2013-02-15 | 5,763 | $5.00 | $28.8K | 2,534,757 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-01 | 2013-02-05 | 9,769 | $4.85 | $47.4K | 2,540,520 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-31 | 2013-02-01 | 18,537 | $4.71 | $87.3K | 2,550,289 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-30 | 2013-02-01 | 11,105 | $5.00 | $55.5K | 2,568,826 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 15,320 | $5.27 | $80.7K | 2,579,931 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 16,660 | $5.40 | $90.0K | 2,595,251 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-25 | 2013-01-28 | 13,790 | $5.38 | $74.2K | 2,611,911 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-24 | 2013-01-28 | 36,324 | $5.45 | $198.0K | 2,625,701 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-23 | 2013-01-24 | 25,354 | $5.11 | $129.6K | 2,662,025 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-22 | 2013-01-24 | 14,966 | $5.02 | $75.1K | 2,687,379 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-18 | 2013-01-22 | 19,080 | $5.19 | $99.0K | 2,702,345 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-17 | 2013-01-22 | 12,615 | $5.35 | $67.5K | 2,721,425 | SEC↗ |